WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (44)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ralph-Williams, R. J.
Right arrow Articles by Geyer, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ralph-Williams, R. J.
Right arrow Articles by Geyer, M. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMPHETAMINE
*APOMORPHINE

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 1, 2002, 22(21):9604-9611

Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice

Rebecca J. Ralph-Williams1, Virginia Lehmann-Masten2, Veronica Otero-Corchon3, Malcolm J. Low3, 4, and Mark A. Geyer2

1 Alcohol and Drug Abuse Research Center, Harvard Medical School and McLean Hospital, Belmont, Massachusetts 02478, 2 Department of Psychiatry, University of California, San Diego, La Jolla, California 92093-0804, 3 Vollum Institute and 4 Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon 97201

Stimulation of the dopamine (DA) system disrupts prepulse inhibition (PPI) of the acoustic startle response. On the basis of rat studies, it appeared that DA D2 receptors (D2Rs) rather than D1 receptors (D1Rs) regulate PPI, albeit possibly in synergism with D1Rs. To characterize the DA receptor modulation of PPI in another species, we tested DA D1R and D2R mutant mice with direct and indirect DA agonists and with the glutamate receptor antagonist, dizocilpine (MK-801). Neither the mixed D1/D2 agonist apomorphine (5 mg/kg) nor the more selective D1-like agonist SKF82958 (0.3 mg/kg) altered PPI in D1R knock-out mice, although both compounds disrupted PPI in D2R mutant and wild-type mice, suggesting that the D1R alone might modulate PPI in mice. However, amphetamine (10 mg/kg) significantly lowered PPI in each genotype of D1R mice, suggesting that the D1R is not necessary for the PPI-disruptive effect of the indirect agonist in mice. As reported previously, amphetamine (10 mg/kg) failed to disrupt PPI in D2R knock-out mice, supporting a unique role of the D2R in the modulation of PPI. Dizocilpine (0.3 mg/kg) induced similar PPI deficits in D1R and D2R mutant mice, confirming that the influences of the NMDA receptor on PPI are independent of D1Rs and D2Rs in rodents. Thus, both D1Rs and D2Rs modulate aspects of PPI in mice in a manner that differs from dopaminergic modulation in rats. These findings emphasize that further cross-species comparisons of the pharmacology of PPI are essential to understand the relevance of rodent PPI studies to the deficits in PPI observed in patients with schizophrenia.

Key words: prepulse inhibition; mice; dopamine; D1 receptor; D2 receptor; knock-out; apomorphine; SKF82958; amphetamine; dizocilpine; startle response


Copyright © 2002 Society for Neuroscience  0270-6474/02/22219604-08$05.00/0


This article has been cited by other articles:


Home page
Schizophr BullHome page
M. van den Buuse
Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
Schizophr Bull, November 9, 2009; (2009) sbp132v1.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. P. Fadok, T. M. K. Dickerson, and R. D. Palmiter
Dopamine Is Necessary for Cue-Dependent Fear Conditioning
J. Neurosci., September 9, 2009; 29(36): 11089 - 11097.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. J. Schmidt, D. S. Chapin, J. Cianfrogna, M. L. Corman, M. Hajos, J. F. Harms, W. E. Hoffman, L. A. Lebel, S. A. McCarthy, F. R. Nelson, et al.
Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 681 - 690.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. B. Caine, M. Thomsen, K. I. Gabriel, J. S. Berkowitz, L. H. Gold, G. F. Koob, S. Tonegawa, J. Zhang, and M. Xu
Lack of Self-Administration of Cocaine in Dopamine D1 Receptor Knock-Out Mice
J. Neurosci., November 28, 2007; 27(48): 13140 - 13150.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
T. L. Petryshen, A. Kirby, R. P. Hammer Jr., S. Purcell, S. B. O'Leary, J. B. Singer, A. E. Hill, J. H. Nadeau, M. J. Daly, and P. Sklar
Two Quantitative Trait Loci for Prepulse Inhibition of Startle Identified on Mouse Chromosome 16 Using Chromosome Substitution Strains
Genetics, December 1, 2005; 171(4): 1895 - 1904.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. J. Ralph and S. B. Caine
Dopamine D1 and D2 Agonist Effects on Prepulse Inhibition and Locomotion: Comparison of Sprague-Dawley Rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J Mice
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 733 - 741.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
K. A. Sacco, K. L. Bannon, and T. P. George
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
J Psychopharmacol, December 1, 2004; 18(4): 457 - 474.
[Abstract] [PDF]


Home page
ScienceHome page
P. Svenningsson, G. G. Nomikos, and P. Greengard
Response to Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"
Science, July 9, 2004; 305(5681): 180d - 180d.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Tsai, R. J. Ralph-Williams, M. Martina, R. Bergeron, J. Berger-Sweeney, K. S. Dunham, Z. Jiang, S. B. Caine, and J. T. Coyle
Gene knockout of glycine transporter 1: Characterization of the behavioral phenotype
PNAS, June 1, 2004; 101(22): 8485 - 8490.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. J. Gerber and S. Tonegawa
Psychotomimetic Effects of Drugs -- A Common Pathway to Schizophrenia?
N. Engl. J. Med., March 4, 2004; 350(10): 1047 - 1048.
[Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-